Jeffrey Damman1, Vincent W Bloks, Mohamed R Daha, Peter J van der Most, Bahram Sanjabi, Pieter van der Vlies, Harold Snieder, Rutger J Ploeg, Christina Krikke, Henri G D Leuvenink, Marc A Seelen. 1. 1 Department of Pathology, Academic Medical Center Amsterdam, the Netherlands. 2 Department of Pediatrics, University Medical Center Groningen, University of Groningen, the Netherlands. 3 Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands. 4 Department of Nephrology, University Medical Center Groningen, Groningen, the Netherlands. 5 Department of Epidemiology, Unit of Genetic Epidemiology and Bioinformatics, University Medical Center Groningen, University of Groningen, the Netherlands. 6 Department of Genetics, University Medical Center Groningen, University of Groningen, the Netherlands. 7 Department of Surgery, University of Oxford, Oxford, United Kingdom. 8 Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands.
Abstract
BACKGROUND: In the last few decades, strategies to improve allograft survival after kidney transplantation have been directed to recipient-dependent mechanisms of renal injury. In contrast, no such efforts have been made to optimize organ quality in the donor. Optimizing deceased donor kidney quality opens new possibilities to improve renal allograft outcome. METHODS: A total of 554 kidney biopsies were taken from donation after brain death (DBD) and donation after cardiac death (DCD) kidneys before donation, after cold ischemia and after reperfusion. Healthy living donor kidney biopsies served as controls. Transcriptomics was performed by whole genome microarray analyses followed by functional pathway analyses. RESULTS: Before organ retrieval and before cessation of blood circulation, metabolic pathways related to hypoxia and complement-and-coagulation cascades were the major pathways enhanced in DBD donors. Similar pathways were also enriched in DCD donors after the first warm ischemia time. Shortly after reperfusion of DCD grafts, pathways related to prolonged and worsening deprivation of oxygen were associated with delayed graft function in the recipient. CONCLUSION: In conclusion, this large deceased donor study shows enrichment of hypoxia and complement-and-coagulation pathways already in DBD donors before cessation of blood flow, before organ retrieval. Therefore, future intervention therapies should target hypoxia and complement-and-coagulation cascades in the donor to improve renal allograft outcome in the recipient.
BACKGROUND: In the last few decades, strategies to improve allograft survival after kidney transplantation have been directed to recipient-dependent mechanisms of renal injury. In contrast, no such efforts have been made to optimize organ quality in the donor. Optimizing deceased donor kidney quality opens new possibilities to improve renal allograft outcome. METHODS: A total of 554 kidney biopsies were taken from donation after brain death (DBD) and donation after cardiac death (DCD) kidneys before donation, after cold ischemia and after reperfusion. Healthy living donor kidney biopsies served as controls. Transcriptomics was performed by whole genome microarray analyses followed by functional pathway analyses. RESULTS: Before organ retrieval and before cessation of blood circulation, metabolic pathways related to hypoxia and complement-and-coagulation cascades were the major pathways enhanced in DBD donors. Similar pathways were also enriched in DCD donors after the first warm ischemia time. Shortly after reperfusion of DCD grafts, pathways related to prolonged and worsening deprivation of oxygen were associated with delayed graft function in the recipient. CONCLUSION: In conclusion, this large deceased donor study shows enrichment of hypoxia and complement-and-coagulation pathways already in DBD donors before cessation of blood flow, before organ retrieval. Therefore, future intervention therapies should target hypoxia and complement-and-coagulation cascades in the donor to improve renal allograft outcome in the recipient.
Authors: Laura J Zitur; Peter J Chlebeck; Scott K Odorico; Juan S Danobeitia; Tiffany J Zens; Cees Van Kooten; Michael Eerhart; Jose A Reyes; Megan L Springer; Jennifer M Coonen; Kevin G Brunner; Saverio V Capuano; Anthony M D'Alessandro; Luis A Fernandez Journal: Transplantation Date: 2019-09 Impact factor: 4.939
Authors: Jing Liu; Sanjeev Kumar; Andreas Heinzel; Michael Gao; Jinjin Guo; Gregory F Alvarado; Roman Reindl-Schwaighofer; A Michaela Krautzberger; Pietro E Cippà; Jill McMahon; Rainer Oberbauer; Andrew P McMahon Journal: J Am Soc Nephrol Date: 2020-02-07 Impact factor: 10.121
Authors: Marc Johnsen; Torsten Kubacki; Assa Yeroslaviz; Martin Richard Späth; Jannis Mörsdorf; Heike Göbel; Katrin Bohl; Michael Ignarski; Caroline Meharg; Bianca Habermann; Janine Altmüller; Andreas Beyer; Thomas Benzing; Bernhard Schermer; Volker Burst; Roman-Ulrich Müller Journal: J Am Soc Nephrol Date: 2020-02-28 Impact factor: 10.121
Authors: Bin Yang; Nicolas Sylvius; Jinli Luo; Cheng Yang; Zhanyun Da; Charlottelrm Crotty; Michael L Nicholson Journal: Front Immunol Date: 2021-07-01 Impact factor: 7.561